Literature DB >> 15956585

Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Hideki Hanawa1, Derek A Persons, Arthur W Nienhuis.   

Abstract

Permanent genetic modification of replicating primitive hematopoietic cells by an integrated vector has many potential therapeutic applications. Both oncoretroviral and lentiviral vectors have a predilection for integration into transcriptionally active genes, creating the potential for promoter activation or gene disruption. The use of self-inactivating (SIN) vectors in which a deletion of the enhancer and promoter sequences from the 3' long terminal repeat (LTR) is copied over into the 5' LTR during vector integration is designed to improve safety by reducing the risk of mobilization of the vector genome and the influence of the LTR on nearby cellular promoters. Our results indicate that SIN vectors are mobilized in cells expressing lentiviral proteins, with the frequency of mobilization influenced by features of the vector design. The mechanism of transcription of integrated vector genomes was evaluated using a promoter trap design with a vector encoding tat but lacking an upstream promoter in a cell line in which drug resistance depended on tat expression. In six clones studied, all transcripts originated from cryptic promoters either upstream or within the vector genome. We estimate that approximately 1 in 3,000 integrated vector genomes is transcribed, leading to the inference that activation of cryptic promoters must depend on local features of chromatin structure and the constellation of nearby regulatory elements as well as the nature of the regulatory elements within the vector.

Mesh:

Substances:

Year:  2005        PMID: 15956585      PMCID: PMC1143763          DOI: 10.1128/JVI.79.13.8410-8421.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Lentivirus vector mobilization and spread by human immunodeficiency virus.

Authors:  J T Evans; J V Garcia
Journal:  Hum Gene Ther       Date:  2000-11-20       Impact factor: 5.695

2.  Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus.

Authors:  J Gribnau; K Diderich; S Pruzina; R Calzolari; P Fraser
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

3.  Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.

Authors:  Hideki Hanawa; Patrick F Kelly; Amit C Nathwani; Derek A Persons; Jody A Vandergriff; Phillip Hargrove; Elio F Vanin; Arthur W Nienhuis
Journal:  Mol Ther       Date:  2002-03       Impact factor: 11.454

Review 4.  HIV-1-derived lentiviral vectors.

Authors:  L E Ailles; L Naldini
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

5.  Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

Authors:  K Xu; H Ma; T J McCown; I M Verma; T Kafri
Journal:  Mol Ther       Date:  2001-01       Impact factor: 11.454

6.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

Authors:  D L Haas; S S Case; G M Crooks; D B Kohn
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

7.  Development of a novel trans-lentiviral vector that affords predictable safety.

Authors:  X Wu; J K Wakefield; H Liu; H Xiao; R Kralovics; J T Prchal; J C Kappes
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

8.  A gene trap vector system for identifying transcriptionally responsive genes.

Authors:  E Medico; G Gambarotta; A Gentile; P M Comoglio; P Soriano
Journal:  Nat Biotechnol       Date:  2001-06       Impact factor: 54.908

9.  Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.

Authors:  T Schnell; P Foley; M Wirth; J Münch; K Uberla
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

10.  Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.

Authors:  J P O'Rourke; G C Newbound; D B Kohn; J C Olsen; B A Bunnell
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  31 in total

1.  Evaluation of residual promoter activity in γ-retroviral self-inactivating (SIN) vectors.

Authors:  Wenqin Xu; Jill L Russ; Maribeth V Eiden
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  Analysis of partial recombinants in lentiviral vector preparations.

Authors:  Seraphin Kuate; Michael P Marino; Jakob Reiser
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

3.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

Review 4.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

5.  Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.

Authors:  Kiyohiko Takayama; Takashi Torashima
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

6.  Reducing the genotoxic potential of retroviral vectors.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2008

7.  Viral Vector Biosafety in Laboratory Animal Research.

Authors:  Dalis E Collins; Jon D Reuter; Howard G Rush; Jason S Villano
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 8.  Engineering humanized mice for improved hematopoietic reconstitution.

Authors:  Adam C Drake; Qingfeng Chen; Jianzhu Chen
Journal:  Cell Mol Immunol       Date:  2012-03-19       Impact factor: 11.530

9.  Cross-packaging of genetically distinct mouse and primate retroviral RNAs.

Authors:  Noura Salem Al Dhaheri; Pretty Susan Phillip; Akela Ghazawi; Jahabar Ali; Elizabeth Beebi; Soumeya Ali Jaballah; Tahir A Rizvi
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

10.  Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair.

Authors:  Rachel M Koldej; Donald S Anson
Journal:  BMC Biotechnol       Date:  2009-10-07       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.